Abstract
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an adult onset hereditary vascular disease with neurological manifestations. The classical clinical course is relentlessly progressive with early transient ischaemic attacks (TIA) or strokes, dementia and finally death in the mid-1960s. The disorder is inherited in an autosomal dominant fashion, with high penetrance and broad variable clinical course even within family. It is caused by mutations in the NOTCH3 gene; all causative mutations result in gain or loss of a cysteine residue within the extracellular domain, with exons 3 and 4 reported as hot spot mutational sites. Mutation analysis of the NOTCH3 gene was performed through direct sequencing of the 2–23 exons containing all EGF-like domains. Patients underwent genetic counselling pre and post testing. Here, we report two novel mutations located in exons 6 and 15 of the NOTCH3 gene; clinical description for the probands and for available relatives is enclosed. No reliable data on incidence or prevalence rates of this disease are available: it is therefore essential that the diagnosis is obtained in all suspected cases through the extensive analysis of the NOTCH3 gene and that all cases are brought to the attention of the scientific community.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CADASIL:
-
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
- TIA:
-
transient ischemic attacks
References
Andreadou E, Papadimas G, Sfagos C (2008) A novel heterozygous mutation in the NOTCH3 gene causing CADASIL. Swiss Med Wkly 138:614–617
Bentley P, Wang T, Malik O et al (2011) CADASIL with cord involvement associated with a novel and atypical NOTCH3 mutation. J Neurol Neurosurg Psychiatry 82:855–860
Bousser MGJ, Tournier-Lasserve E (2001) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: from stroke to vessel wall physiology. J Neurol Neurosurg Psychiatry 70:285–287
Chabriat H, Joutel A, Vahedi K, Iba-Zizen MT, Tournier-Lasserve E, Bousser MG (1996) CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). J Mal Vasc 215:277–282
Chabriat H, Joutel A, Vahedi K, Iba-Zizen MT, Tournier-Lasserve E, Bousser MG (1997) CADASIL. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Rev Neurol (Paris) 153:376–385
Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG (2009) CADASIL. Lancet Neurol 8:643–653
Di Maio G, Formichi P, Radi E et al (2012) Human peripheral blood lymphocytes and fibroblasts as Notch3 expression models. J Cell Physiol 227:1771–1775
Dotti MT, Federico A, Mazzei R et al (2005) The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry 76:736–738
Federico A, Bianchi S, Dotti MT (2005) The spectrum of mutations for CADASIL diagnosis. Neurol Sci 26:117–124
Granild-Jensen J, Jensen UB, Schwartz M, Hansen US (2009) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy resulting in stroke in an 11-year-old male. Dev Med Child Neurol 51:754–757
Guerreiro RJ, Lohmann E, Kinsella E et al (2012) Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer’s disease. Neurobiol Aging 33:e17–e23
Guidetti D, Casali B, Mazzei RL et al (2003) An Italian case of CADASIL with mutation CGC-TCG in codon 1006, exon 19 Notch3 gene. Neurol Sci 24:401–406
Hervé D, Chabriat H (2010) CADASIL. J Geriatr Psychiatry Neurol 23:269–276
Lee SJ, Meng H, Elmadhoun O, Blaivas M, Wang MM (2011) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy affecting an African American man. Arch Neurol 68:1584–1586
Louvi A, Artavanis-Tsakonas S (2012) Notch and disease: a growing field. Semin Cell Dev Biol 23:473–480
Markus HS, Martin RJ, Simpson MA et al (2002) Diagnostic strategies in CADASIL. Neurology 59:1134–1138
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human necleated cells. Nucleic Acids Res 16:1215
Mosca L, Marazzi R, Ciccone A et al (2011) NOTCH3 gene mutations in subjects clinically suspected of CADASIL. J Neurol Sci 307:144–148
Pantoni L, Pescini F, Nannucci S et al (2010) Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients. Neurology 74:57–63
Pradotto L, Azan G, Doriguzzi C, Valentini C, Mauro A (2008) Sporadic vascular dementia as clinical presentation of a new missense mutation within exon 7 of NOTCH3 gene. J Neurol Sci 271:207–210
Razvi SS, Davidson R, Bone I, Muir KW (2005) The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry 76:739–741
Reyes S, Kurtz A, Hervé D et al (2012) Presymptomatic genetic testing in CADASIL. J Neurol 259:2131–2136
Rufa A, Guideri F, Acampa M et al (2007) Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Stroke 38:276–280
Saiki S, Sakai K, Saiki M et al (2006) Varicose veins associated with CADASIL result from a novel mutation in the Notch3 gene. Neurology 67:337–339
Tarlarini C, Marazzi R, Spanò F, Mosca L, Primignani P, Penco S (2012) Cardiomiopatia dilatativa e sofferenza cerebrovascolare in paziente con mutazione in NOTCH3. Convegno monotematico SIF: nuove frontiere nella terapia dell’aterosclerosi. Milano 03/02/2012
Testi S, Malerba G, Ferrarini M et al (2012) Mutational and haplotype map of NOTCH3 in a cohort of Italian patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). J Neurol Sci 319:37–41
Tournier-Lasserve E, Joutel A, Melki J et al (2003) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 3:256–259
Ungaro C, Mazzei R, Conforti FL et al (2009) CADASIL: extended polymorphisms and mutational analysis of the NOTCH3 gene. J Neurosci Res 87:1162–1167
Walker FO (2007) Huntington’s disease. Lancet 369:218–228
Weiming F, Yuliang W, Youjie L, Xinsheng L, Shuyang X, Zhaoxia L (2013) A novel Notch3 deletion mutation in a Chinese patient with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). J Clin Neurosci 20:322–323
Williamson EE, Chukwudelunzu FE, Meschia JF, Witte RJ, Dickson DW, Cohen MD (1999) Distinguishing primary angiitis of the central nervous system from cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: the importance of family history. Arthritis Rheum 42:2243–2248
World Medical Association (WMA) declaration of Helsinki (1997) Recommendations guiding physicians in biomedical research involving human subjects. J Am Med Assoc 277:925–926
Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN (2011) Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol 37:94–113
Acknowledgments
We would like to thank the patients and their families.
Competing interests
None
Funding
This work was not supported by funds.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mosca, L., Rivieri, F., Tanel, R. et al. Mutational Screening of NOTCH3 Gene Reveals Two Novel Mutations: Complexity of CADASIL Diagnosis. J Mol Neurosci 54, 723–729 (2014). https://doi.org/10.1007/s12031-014-0311-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-014-0311-x